JPRN-UMIN000004368已完成2 期
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016) - Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)
Thoracic Oncology Research Group0 个研究点目标入组 47 人开始时间: 2010年10月12日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) brain metastasis 2) histroy of hemoptysis 3) serious complication; cardiac disea se, interstitial peumonia, diabetes, active infection 4) massive pleural or pericardial effusion, ascites 5) concomitant malignancy 6) uncontrollable peptic ulcer or GI perforaion within 1 year 7) uncontrollable hypertension 8) anticoagulation therapy 9) inappropriate for this study judged by the attending physician
研究者
相似试验
已完成
1 期
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
未知
2 期
A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.advanced gastric cancerJPRN-UMIN000000801Dept. of Internal Medicine(4)30
招募中
2 期
Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancerpatients with metastatic penile cancerJPRN-UMIN000002697Fudan University Shanghai Cancer Center40
进行中（未招募）
不适用
Multicenter phase II study evaluating docetaxel, CDDP, and cetuximab as induction regimen prior to surgery in chemonaive patients with NSCLC stage IB, II, and IIIA. - INN06eoadjuvant treatment of non-small lung cancerEUCTR2006-004639-31-ATTAKO
已完成
2 期
A phase II study of docetaxel/carboplatin as secondline treatment in patients with refractory or relapsed SCLCrefractory small cell lungcancerSCLC-ED10006436NL-OMON33924Jeroen Bosch Ziekenhuis50